Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-1 Trial of Nebulized…
LONDON and RALEIGH, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the "Company"), a clinical-stage biopharmaceutical company focused on…